TABLE 3.
Sensitivity and specificity of SLID-R prediction with known markersa
| Drug | No. of isolates |
Sensitivity (%) (95% CI) | Specificity (%) (95% CI) | |||
|---|---|---|---|---|---|---|
| Explained resistant | Explained susceptible | Unexplained resistant | Unexplained susceptible | |||
| AMK | 276 | 829 | 51 | 27 | 84.3 (82.1–86.3) | 96.8 (95.6–97.7) |
| CAP | 250 | 813 | 74 | 22 | 77.2 (74.6–79.5) | 97.4 (96.2–98.2) |
| KAN | 249 | 223 | 21 | 3 | 92.3 (89.6–94.4) | 98.7 (97.1–99.4) |
a
A 95% confidence interval for each estimate was calculated using the score method with continuity correction (64). Isolates with genotypic-phenotypic concordance were classified as “explained.” Otherwise, they are “unexplained.”